ArticleBMJ open2025

Anti-inflammatory therapy for recurrent in-stent restenosis (AI-ISR): study protocol for a prospective, randomised, open-label, multicentre clinical trial.

Miao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.